159 related articles for article (PubMed ID: 15294951)
1. Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes.
Li G; Domenico J; Lucas JJ; Gelfand EW
J Immunol; 2004 Aug; 173(4):2383-91. PubMed ID: 15294951
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo.
Gómez Lahoz E; Liegeois NJ; Zhang P; Engelman JA; Horner J; Silverman A; Burde R; Roussel MF; Sherr CJ; Elledge SJ; DePinho RA
Mol Cell Biol; 1999 Jan; 19(1):353-63. PubMed ID: 9858559
[TBL] [Abstract][Full Text] [Related]
3. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
Joaquin M; Watson RJ
J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
[TBL] [Abstract][Full Text] [Related]
4. p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts.
Reynaud EG; Pelpel K; Guillier M; Leibovitch MP; Leibovitch SA
Mol Cell Biol; 1999 Nov; 19(11):7621-9. PubMed ID: 10523650
[TBL] [Abstract][Full Text] [Related]
5. Identification of a functional glucocorticoid response element in the promoter of the cyclin-dependent kinase inhibitor p57Kip2.
Alheim K; Corness J; Samuelsson MK; Bladh LG; Murata T; Nilsson T; Okret S
J Mol Endocrinol; 2003 Jun; 30(3):359-68. PubMed ID: 12790805
[TBL] [Abstract][Full Text] [Related]
6. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.
Tury A; Mairet-Coello G; DiCicco-Bloom E
Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411
[TBL] [Abstract][Full Text] [Related]
7. Periodic expression of the cyclin-dependent kinase inhibitor p57(Kip2) in trophoblast giant cells defines a G2-like gap phase of the endocycle.
Hattori N; Davies TC; Anson-Cartwright L; Cross JC
Mol Biol Cell; 2000 Mar; 11(3):1037-45. PubMed ID: 10712518
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of MyoD by direct binding to p57(Kip2).
Reynaud EG; Leibovitch MP; Tintignac LA; Pelpel K; Guillier M; Leibovitch SA
J Biol Chem; 2000 Jun; 275(25):18767-76. PubMed ID: 10764802
[TBL] [Abstract][Full Text] [Related]
9. Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes.
Lucas JJ; Szepesi A; Modiano JF; Domenico J; Gelfand EW
J Immunol; 1995 Jun; 154(12):6275-84. PubMed ID: 7759865
[TBL] [Abstract][Full Text] [Related]
10. A Beckwith-Wiedemann-Associated
Stampone E; Bencivenga D; Barone C; Di Finizio M; Della Ragione F; Borriello A
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299047
[TBL] [Abstract][Full Text] [Related]
11. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
Matsuoka S; Edwards MC; Bai C; Parker S; Zhang P; Baldini A; Harper JW; Elledge SJ
Genes Dev; 1995 Mar; 9(6):650-62. PubMed ID: 7729684
[TBL] [Abstract][Full Text] [Related]
12. The multiple roles of the cyclin-dependent kinase inhibitory protein p57(KIP2) in cerebral cortical neurogenesis.
Tury A; Mairet-Coello G; DiCicco-Bloom E
Dev Neurobiol; 2012 Jun; 72(6):821-42. PubMed ID: 22076965
[TBL] [Abstract][Full Text] [Related]
13. p57(Kip2) regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina.
Dyer MA; Cepko CL
Development; 2000 Aug; 127(16):3593-605. PubMed ID: 10903183
[TBL] [Abstract][Full Text] [Related]
14. Association of proliferating cell nuclear antigen with cyclin-dependent kinases and cyclins in normal and transformed human T lymphocytes.
Szepesi A; Gelfand EW; Lucas JJ
Blood; 1994 Nov; 84(10):3413-21. PubMed ID: 7949095
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells.
Nakano N; Urasawa K; Takagi Y; Saito T; Kaneta S; Ishikawa S; Higashi H; Tsutsui H; Hatakeyama M; Kitabatake A
Biochem Biophys Res Commun; 2005 Dec; 338(3):1661-7. PubMed ID: 16259944
[TBL] [Abstract][Full Text] [Related]
16. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
Lee MH; Reynisdóttir I; Massagué J
Genes Dev; 1995 Mar; 9(6):639-49. PubMed ID: 7729683
[TBL] [Abstract][Full Text] [Related]
17. Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer.
Liang B; Wang S; Yang X; Ye Y; Yu Y; Cui Z
Chin Med J (Engl); 2003 Jan; 116(1):20-3. PubMed ID: 12667381
[TBL] [Abstract][Full Text] [Related]
18. Rapid nuclear translocation and increased activity of cyclin-dependent kinase 6 after T cell activation.
Nagasawa M; Melamed I; Kupfer A; Gelfand EW; Lucas JJ
J Immunol; 1997 Jun; 158(11):5146-54. PubMed ID: 9164930
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R
Oncogene; 1998 Oct; 17(14):1827-36. PubMed ID: 9778049
[TBL] [Abstract][Full Text] [Related]
20. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.
Yan Y; Frisén J; Lee MH; Massagué J; Barbacid M
Genes Dev; 1997 Apr; 11(8):973-83. PubMed ID: 9136926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
